PharmaHub · Veterinary & Animal Health · Global

Companion Animal Rehabilitation Services Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The companion animal rehabilitation services market encompasses professional therapeutic care for pets, primarily dogs and cats, including post-surgical recovery programs, physical therapy, orthopedic treatments, and mobility support services provided through veterinary clinics and specialized rehabilitation centers. The market was valued at approximately $577 to $635 million in 2024-2025, with projections varying by source to reach between $1.15 billion and $1.4 billion by 2030-2032 at a compound annual growth rate of roughly 11 to 12 percent. Growth is fueled by rising pet ownership and spending, an aging companion animal population, increasing prevalence of orthopedic disorders and chronic conditions, expanding pet insurance coverage, and the broader trend of pet humanization where owners increasingly seek human-grade medical care for their animals.

Market size · 2025
$640 million
CAGR · 2025–2030
11.8%
Forecast · 2030
$1.1 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $640M2030 est: $1.1bn
Read the full Companion Animal Rehabilitation Services Market Report report →

Market Overview

The companion animal rehabilitation services market includes physical therapy, hydrotherapy, therapeutic exercises, laser therapy, acupuncture, and other modalities designed to restore function and improve quality of life for pets recovering from surgery, injury, or managing chronic conditions. Dogs represent the largest animal segment, while therapeutic exercises and post-surgical care dominate the therapy categories. The market encompasses services delivered through veterinary hospitals, specialty rehabilitation clinics, and mobile therapy units.

  • Market valued at approximately $577 million to $635 million in 2024-2025 depending on research methodology and scope
  • Projected to reach $1.15 billion to $1.4 billion by 2030-2032 with CAGRs ranging from 11.2% to 12.01%
  • Dogs account for the largest share of animal patients, followed by cats
  • Post-surgical care and therapeutic exercises are the dominant therapy categories

Growth Drivers

The primary engine of market expansion is the human-animal bond, which has intensified pet humanization trends and led owners to demand advanced medical treatments comparable to human healthcare. An aging pet population is driving higher incidence of orthopedic disorders, arthritis, and mobility issues that require rehabilitation. Rising pet insurance coverage is reducing out-of-pocket costs for owners, while advancements in veterinary medicine and rehabilitation equipment are expanding the range of treatable conditions.

  • Pet humanization and the strengthening human-animal bond are driving demand for specialized medical care matching human physiotherapy standards
  • An aging companion animal population with rising prevalence of orthopedic disorders, arthritis, and chronic conditions is increasing patient volumes
  • Expanding pet insurance coverage and rising pet healthcare expenditures are improving owner willingness to pay for rehabilitation services
Want a deeper cut on Companion Animal Rehabilitation Services Market Report? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

By animal type, dogs dominate the market due to higher rates of orthopedic conditions and greater participation in post-surgical rehabilitation protocols, with cats representing a smaller but growing segment. Therapy categories include post-surgical care, therapeutic exercises, hydrotherapy, laser therapy, and mobility support devices. Geographically, North America holds the leading regional position, supported by high pet ownership rates, advanced veterinary infrastructure, and widespread pet insurance adoption.

  • Dogs represent the leading animal segment, with higher demand driven by orthopedic conditions and post-surgical recovery needs
  • Therapeutic exercises and post-surgical care are the dominant therapy categories, followed by hydrotherapy and laser treatments
  • North America holds the leading regional market position, with strong growth also occurring in Europe and Asia-Pacific as pet ownership rises

Trends and Outlook

What are the recent trends and outlook?

The market is expected to sustain its double-digit growth trajectory through 2035 as continued pet humanization, rising disposable incomes in emerging markets, and technological innovations in veterinary rehabilitation expand addressable demand. Increasing adoption of evidence-based therapeutic protocols and integration of human physiotherapy techniques into veterinary practice are improving treatment outcomes and market credibility. The long-term outlook remains strongly positive as companion animals are increasingly regarded as family members, driving sustained investment in specialized medical services including rehabilitation.

  • Market projections extend to 2035 with forecasts ranging from $2.08 billion to over $2.4 billion as the market sustains high single-digit to low double-digit growth
  • Growing integration of human physiotherapy techniques and evidence-based protocols is elevating the standard of care in veterinary rehabilitation
  • Emerging markets in Asia-Pacific and Latin America present growth opportunities as pet ownership and veterinary infrastructure continue to expand
Talk to a Claight analyst
Do you want to research Companion Animal Rehabilitation Services Market Report?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.